Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News GSK plc GSK

Consumer Cyclical Drug Manufacturers - Major
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through Commercial Operations and Total R&D segments. The company offers specialty medicines that include oncology, respiratory/immunology... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NYSE:GSK)

Bora Pharmaceuticals and GSK Sign $250M Five Year Global Manufacturing Contract

Business Wire 10 days ago

GSK's AREXVY Associated With Reductions in Certain RSV-Related Risks Including Heart Attack, Stroke and Severe Flare-Ups of COPD and Asthma, Real World Study Shows

Business Wire February 18, 2026

GSK Awards $2M in COiMMUNITY Initiative Grants to Help Close Vaccination Gaps, Commits $3M for 2026

Business Wire January 21, 2026

GSK Announces Recipients of Linked by Lupus: Optimal Care Initiative Grants Nearing $1 Million

Business Wire January 20, 2026

Exdensur (depemokimab) approved by US FDA for the treatment of severe asthma

Business Wire December 16, 2025

Blenrep approved by US FDA for use in treatment of relapsed/refractory multiple myeloma

Business Wire October 23, 2025

PIVOT-PO Phase 3 Data Show Tebipenem HBr's Potential as the First Oral Carbapenem Antibiotic for Patients with Complicated Urinary Tract Infections (cUTIs)

GlobeNewswire October 21, 2025

New Local Data in GSK and IQVIA's Vaccine Track Supports Smarter Public Health Action at the Community Level

Business Wire October 1, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GSK plc - GSK

PR Newswire September 3, 2025
View More News ››

Opinion & Analysis (NYSE:GSK)

Opportunities in cancer immunotherapy throttle up: George Zavoico of JonesTrading

George S. Mack June 25, 2015

Drug ETFs Surge On M&A Activity (AGN, VRX, IHE, XPH, PPH, AZN)

Benzinga.com  April 22, 2014

Everyone gets the flu

Marc Lichtenfeld March 6, 2013

Cash in on the growing Chinese pharmaceutical market

Tony D'Altorio September 10, 2010

Big Pharma has a big problem and merger mania is heating up

Marc Lichtenfeld July 29, 2010

Stock market myth: share buybacks work

Andrew Mickey October 29, 2008
View More Opinion ››

Bullboard Posts (NYSE:GSK)

Great News !!!! this would be amazing !!

https://www.washingtonpost.com/health/2022/06/08/cancer-drug-trial/ https://nationalpost.com/health/small-cancer-drug-trial-sees...
Thunde - June 9, 2022

Glaxo

Doesn't sell the cure Glaxo Sells the disease
Rainbowflier - May 4, 2022

5% divided with huge upside with split

This company will be more profitable once they split up work it as two companies. Their pipeline of drugs and monoclonal antibody...
CBalardo - October 20, 2021

Bonvoyage12....Lying Pumper

Ignore this clown as he posts lies trying to mislead investors about the actual state of the company...he also posts this same BS on...
Mil_Man54 - December 26, 2020

Why is it so low

I don't understand why this stock is even lower than before the pandemic. They have the potential to enter in the Covid vaccine...
IamMagic - December 1, 2020

This is supposed to be Glasgow Smith Kline!

Seems Stockhouse can't get anything right
prested - November 22, 2016
View more Bullboard ››

Cielo Waste Solutions Corp.

Cielo Waste Solutions Corp.

Cielo Waste Solutions Corp. operates as a waste to fuels company, focuses on wood waste byproducts conversion to renewable ...
View More »

Podcasts